Physician Assistant · Twentynine Palms, CA
NPI
1497196729
Since 2013
Specialty
Physician Assistant
Code 363A00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
72724 29 Palms Hwy, Suite 103
Twentynine Palms, CA, 92277
Phone (760) 367-5906
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$447K
4,623 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Moheen Suna-Sitto prescribed most often to Medicare patients was Atorvastatin Calcium, with 319 prescriptions and refills. In total Moheen Suna-Sitto wrote 4,623 Medicare prescriptions that cost $447K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-07-15.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 319 | 341 | 38 | $11K |
| Amlodipine Besylate Generic | 209 | 227 | 28 | $3,110 |
| Gabapentin Generic | 206 | 221 | 31 | $4,326 |
| Metformin Hcl Generic | 203 | 218 | 26 | $2,701 |
| Lisinopril Generic | 202 | 214 | 26 | $2,432 |
| Tamsulosin Hcl Generic | 169 | 185 | 22 | $6,959 |
| Omeprazole Generic | 146 | 160 | 22 | $3,867 |
| Losartan Potassium Generic | 137 | 154 | 15 | $1,966 |
| Levothyroxine Sodium Generic | 124 | 129 | 14 | $1,463 |
| Pantoprazole Sodium Generic | 122 | 125 | 15 | $4,808 |
| Famotidine Generic | 122 | 134 | 19 | $2,459 |
| Simvastatin Generic | 116 | 122 | 12 | $1,720 |
| Rosuvastatin Calcium Generic | 113 | 128 | 13 | $8,627 |
| Finasteride Generic | 110 | 116 | 14 | $3,330 |
| Metoprolol Succinate Generic | 53 | 61 | Under 11 | $695 |
Brand drugs: 589 claims; generic drugs: 3,996 claims; opioid claims: 38.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Moheen Suna-Sitto were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.